このアイテムのアクセス数: 14

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
bjh.19372.pdf1.01 MBAdobe PDF見る/開く
タイトル: First complete remission favours haploidentical haematopoietic stem cell transplantation with post-transplant cyclophosphamide over cord blood transplantation in acute lymphoblastic leukaemia
著者: Jo, Tomoyasu
Ueda, Tomoaki
Akahoshi, Yu
Kondo, Tadakazu
Uchida, Naoyuki
Tanaka, Masatsugu
Nakamae, Hirohisa
Doki, Noriko
Ota, Shuichi
Sawa, Masashi
Ohigashi, Hiroyuki
Maruyama, Yumiko
Takayama, Nobuyuki
Nishida, Tetsuya
Hiramoto, Nobuhiro
Katayama, Yuta
Kanda, Yoshinobu
Ichinohe, Tatsuo
Atsuta, Yoshiko
Arai, Yasuyuki  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0002-9662-5093 (unconfirmed)
The Japanese Society for Transplantation and Cellular Therapy (JSTCT)
著者名の別形: 城, 友泰
新井, 康之
キーワード: acute lymphoblastic leukaemia
HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide
umbilical cord blood
発行日: May-2024
出版者: Wiley
誌名: British Journal of Haematology
巻: 204
号: 5
開始ページ: 1913
終了ページ: 1919
抄録: To assess the benefits of HLA-haploidentical haematopoietic stem cell transplantation using post-transplant cyclophosphamide (PTCy-haplo) relative to those of umbilical cord blood (UCB) transplantation in acute lymphoblastic leukaemia (ALL), we analysed 1999 patients (PTCy-haplo, 330; UCB, 1669), using the nationwide Japanese registry. PTCy-haplo was associated with a significantly higher relapse rate, but lower non-relapse mortality, which results in overall survival and disease-free survival, comparable to those of UCB. Among patients in CR1, PTCy-haplo showed a significantly higher survival than UCB regardless of the CD34⁺ cell dose. Our findings provide valuable insights into the donor selection algorithm in allogeneic HSCT for adult patients with ALL.
記述: 急性白血病におけるHLA半合致移植と臍帯血移植の比較 ―症例に応じた最適な造血幹細胞移植を目指して―. 京都大学プレスリリース. 2024-03-04.
著作権等: © 2024 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
URI: http://hdl.handle.net/2433/293598
DOI(出版社版): 10.1111/bjh.19372
PubMed ID: 38420726
関連リンク: https://www.kyoto-u.ac.jp/ja/research-news/2024-03-04-0
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons